141 related articles for article (PubMed ID: 9762631)
21. Delayed gastric emptying after operation for obstructing peptic ulcer disease: the influence of cimetidine.
Smale BF; Copeland JG; Reber HA
Surgery; 1984 Oct; 96(4):592-8. PubMed ID: 6484803
[TBL] [Abstract][Full Text] [Related]
22. Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures.
Barbezat GO; Schlup M; Lubcke R
Aliment Pharmacol Ther; 1999 Aug; 13(8):1041-5. PubMed ID: 10468679
[TBL] [Abstract][Full Text] [Related]
23. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
Guerreiro AS; Neves BC; Quina MG
Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
Takeyama Y; Matsui T; Yao T; Motomura A; Arita M; Okada M; Tanaka K; Imamura T; Hatakeyama S
Nihon Shokakibyo Gakkai Zasshi; 1999 May; 96(5):502-10. PubMed ID: 10368993
[TBL] [Abstract][Full Text] [Related]
25. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
de Bruijne JW; Lamers CB
Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
[No Abstract] [Full Text] [Related]
26. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.
Khoshbaten M; Fattahi E; Naderi N; Khaleghian F; Rezailashkajani M
BMC Gastroenterol; 2006 Jan; 6():2. PubMed ID: 16403233
[TBL] [Abstract][Full Text] [Related]
27. Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.
García Rodríguez LA; Ruigómez A
Epidemiology; 1999 May; 10(3):228-32. PubMed ID: 10230829
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.
Bate CM; Green JR; Axon AT; Tildesley G; Murrays FE; Owen SM; Emmas C; Taylor MD
Aliment Pharmacol Ther; 1998 Jan; 12(1):41-7. PubMed ID: 9692699
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
30. Peptic pyloric stenosis treated by endoscopic balloon dilatation.
Griffin SM; Chung SC; Leung JW; Li AK
Br J Surg; 1989 Nov; 76(11):1147-8. PubMed ID: 2597970
[TBL] [Abstract][Full Text] [Related]
31. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA
Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
[TBL] [Abstract][Full Text] [Related]
32. [Duodenal peptic ulcer. Medical therapy].
Villalobos Pérez JJ
Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
[No Abstract] [Full Text] [Related]
33. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
[TBL] [Abstract][Full Text] [Related]
34. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
[TBL] [Abstract][Full Text] [Related]
36. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
Alekseenko SA; Timoshin SS
Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
[TBL] [Abstract][Full Text] [Related]
37. Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers.
Libby ED
N Engl J Med; 2000 Aug; 343(5):358-9. PubMed ID: 10922427
[No Abstract] [Full Text] [Related]
38. [Drug therapy of peptic ulcer disease].
Pikkarainen P
Duodecim; 1991; 107(13):1097-102. PubMed ID: 1365337
[No Abstract] [Full Text] [Related]
39. [Long-term results of endoscopic balloon dilatation of ulcer-induced pyloric stenoses--follow-up of 25 patients].
Schilling D; Martin WR; Benz C; Kress S; Riemann JF
Z Gastroenterol; 1997 Feb; 35(2):105-8. PubMed ID: 9163225
[TBL] [Abstract][Full Text] [Related]
40. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
Contraşiu P; Calinici V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
